Switch to:
GuruFocus articles
Headlines from internet
Jan-18-18$46.51 (-0.58%)
05:35PMAnalyst Reaffirms Buy Rating on Endo, Mylan Amid Hospitals' Potential Drug Foray theStreet
02:40PMWhy hospital entry won’t hurt the generic drug business MarketWatch
Jan-16-18$46.64 (-0.55%)
09:02AMTeva's Trisenox Gets FDA Approval as First-Line Treatment Zacks
Jan-12-18$46.9 (+0.41%)
11:27AM$DEX $NXRT $RE $SWZ $SHLD $TEI $RMPLX $CYH $WDAY $SSD $SAMG $MYL $GPI $CRM $BOX $STX $S $KMG $DVMT $ANDV Daily Insider Ratings Round 1 10 18 Shld Re Swz Dex Nxrt Seekingalpha
09:47AM$LPCN $NVAX $ABT $AXON $AZN $BSX $CANF $CBAY $CBDS $CELG $CRSP $EPZM $EXAS $FOLD $GMED $IMDZ $ITCI $LCI $MDCL $MYL Daily Pharma Scoop Abbvie Highlights Pipeline Novavax Surges Lipocine Flops Ad Com Seekingalpha
Jan-11-18$46.71 (+5.23%)
02:51PM$MYL Mylan Time Ripe Seekingalpha
Jan-09-18$44.29 (-0.61%)
09:12PMMylan sees opportunity in rival Teva’s weakness MarketWatch
10:10AMAllergan's (AGN) Sales Guidance for 2018 Lower Than Expected Zacks
Jan-08-18$44.56 (+0.04%)
05:23PMMomenta Reports Positive Top-Line Data on Antibody M281 Zacks
Jan-05-18$44.54 (+0.52%)
02:16PMWhy Momenta Pharmaceuticals Rallied 15.6% Today Fool
07:26AMKey Biosimilar Approvals in 2017: Progress Report Zacks
06:20AMPharma Stock Roundup: Allergan Announces Job Cuts, Pfizer Inks Deals Zacks
Jan-04-18$44.31 (+2.71%)
03:35PMAllergan to Cut Jobs Amid Loss of Exclusivity for Key Drugs Zacks
10:49AMBlizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports theStreet
07:35AMMomenta & Mylan to Initiate Trial on Biosimilar of Eylea Zacks
Jan-02-18$43.11 (+1.89%)
05:35PMDrug companies may have shorted government more than $1 billion in Medicaid rebates cnbc
07:30AM$AGN $TEVA $VRX $MYL Generic Alpha Mylan Story Seekingalpha
12:05AM$MYL $TEVA $AGN New Patent Ruling Doom Allergans Mohawk Deal Seekingalpha
Dec-20-17$41.22 (-0.05%)
08:33AM3 Top Generic Drug Stocks to Consider Buying Now Fool
Dec-19-17$41.24 (-1.03%)
09:04AMTeva's Migraine Candidate Gets Priority Review From FDA Zacks
Dec-18-17$41.67 (+2.84%)
07:03AMThe 5 Best-Selling Drugs of 2017 Fool
12:04PM$MYL $TEVA Teva Aggressive Cuts Provide Relief Seekingalpha
Dec-15-17$40.52 (+1.27%)
03:52PMMylan Announces IPR Proceedings for Sanofi's Lantus Patents Zacks
01:17PM$MYL $TEVA Teva Really 5 Billion Debt Payments Due Next Year Seekingalpha
Dec-14-17$40.01 (+1.21%)
01:46PMWhy Teva Pharmaceutical Is Soaring 13.5% Today Fool
11:00AMTeva to lay off 14,000 workers in bid for survival — but some are skeptical MarketWatch
Dec-13-17$39.53 (+0.61%)
01:44PM$MYL $PFE $ADMP Can Adamis Bleed Mylan Dry Seekingalpha
Dec-11-17$39.49 (+2.12%)
02:38AM$LLY $MDGL $MYL $TEVA $PFE $SAGE $VKTX Biotech Analysis Central Pharma News Sages Depression Results Pfizers Viagra Move Vikings Run Seekingalpha
Dec-08-17$38.67 (+3.48%)
06:40AMPharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz Zacks
Dec-06-17$36.99 (-1.12%)
09:35AM3 Top Value Stocks to Buy in December Fool
07:45AM$MRK $MYL $NVS $SNY $ALXN $BMRN $REGN $VRX $OMER Pharma Life Sciences M Activity Shows Omeros Corporation Extremely Undervalued Seekingalpha
Dec-05-17$37.41 (-0.08%)
11:07AM$MYL $SNY $VRX $ADMP $HRTX $NVAX $PGNX Watch December Biotech Catalysts Seekingalpha
Dec-04-17$37.44 (-1.78%)
11:48AM3 Things You Must Know About Wall Street as You Head to Lunch theStreet
09:35AMAnalysts expect these large-cap U.S. stocks to rise at least 25% in 2018 MarketWatch
08:46AMMylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest Zacks
07:21AMWill the Healthcare Landscape Change with the $69B CVS-Aetna Deal? Zacks
11:06PM$EXAS $MYL $REGN $TEVA $VRX Next Stop Valeant Pharmaceuticals Stock 19 Seekingalpha
08:00AM$AMGN $ARDM $GRFS $MYL $BCNQY 3 Things Biotech Learn Today December 3 2017 Seekingalpha
Dec-01-17$38.12 (+3.42%)
04:58PM3 Drug/Biotech Stocks in Focus on World AIDS Day Zacks
04:30PMWhy Ambarella, Foundation Medicine, and Mylan Jumped Today Fool
02:30PMOn The Eve of CVS-Aetna Deal, All Eyes Are on Amazon theStreet
01:32PMMylan and Teva stocks rise on report about Amazon’s pharmacy aims MarketWatch
12:47PM$ALT $AMGN $AMPH $ARDM $BIIB $BLUE $GILD $GSK $LXRX $MCOA $MDCO $MNK $MRUS $MYL $OFIX $REPH $RHHBY $RYTM $SNOA Daily Pharma Scoop Dynavax Beyond Heplisav B Novartis Cosentyx Shire Granted Odd Seekingalpha
10:07AMMorning Movers: Ulta Tanks on Earnings; Sanofi Slips on Downgrade Barron's
08:56AMMorning Movers: Ulta Tanks on Earnings; Sanofi Slips on Downgrade Barron's
08:33AMCancer Space Update: Pfizer's Bavencio Fails in Phase III Zacks
08:00AM$BCNQY $FMI $GSK $MRTX $MYL $RHHBY 3 Things Biotech Learn Today December 1 2017 Seekingalpha
07:50AMAmazon's Move Into Retail Pharmacy Could Put 10% of Industry Profits at Risk theStreet
07:07AM$SPY $QQQ $AAPL $ABC $AMZN $APRN $CAH $DIS $INTC $MCK $MSFT $MYL $NSANY $NVS $QCOM $SHLD $TOSYY $TSLA $UAA $VLKAY Wall Street Breakfast Tax Concerns Weigh Stock Futures Seekingalpha
06:01AMSenate Tax Bill, Car Sales and Amazon - 5 Things You Must Know Before the Market Opens Friday theStreet
05:13AMTech stocks set to lead downturn for U.S. stocks a day after Dow smashes through 24,000 MarketWatch
05:00AMPharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Changes Zacks
09:06PMBarron’s After Hours: Mylan Jumps, Ambarella Gains, Ulta Beauty Slumps Barron's
05:29PMMylan shares jump after report Amazon is in talk with generic drug makers MarketWatch
05:23PMAmazon has discussed pharmacy business with generic drugmakers: report MarketWatch
02:29PMWhen it comes to high drug prices, Big Pharma blames someone else MarketWatch
08:19AMGlaxo Stock Down So Far This Year: Is a Reversal in Store? Zacks
07:51AM$MYL $ADMP Adamis Pharmaceuticals Rocket Still Launchpad Seekingalpha
07:18AM5 Biotech and Pharma Stocks with FDA Catalysts this December Zacks
12:19AM$IPXL $MYL $SNY $MNKD Fdas Less Stringent Regulations Help Mannkind Seekingalpha
Nov-29-17$36.86 (-0.05%)
07:34AM$ACOR $ALKS $ARDX $BHVN $BIIB $CRSP $ICPT $KYKOF $LGND $MRK $MYL $REGN $SGYP $TEVA $TRTC $TSRO $XNCR $EARS $EGLT Daily Pharma Scoop Omeros Buts Egalets Oxycodone Success Auris Flunks Study Seekingalpha
02:01AM$BAYN $BIIB $CELG $MYL $NVS $REGN $RHHBY $TEVA $VKTX Biotech Analysis Central Pharma News Regenerons Flop Vikings Trial Success Biogens Ms Deal Seekingalpha
Nov-28-17$36.88 (+1.15%)
09:41AMFDA issues guidance that could make it easier for EpiPen rivals to come to market cnbc
07:46AMTeva's New CEO Re-Shuffles Senior Management, Stock Up 7% Zacks
Nov-27-17$36.46 (-2.44%)
08:04AMTax reform could make it less worthwhile to own companies that have done inversions $ETN $MDT $AGN $JCI $MYL $ENDP Barron's
Nov-24-17$37.37 (+0.24%)
01:11PMJ&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space Zacks
12:25PMTeva (TEVA) Stock Rises 5% on Reports of Massive Job Cuts Zacks
02:40AMStruggling Teva Announces Mass Layoffs Seekingalpha
Nov-20-17$36.5 (-2.9%)
03:35PMApplying Risk Checklist General Electric Mylan Seekingalpha
Nov-17-17$37.59 (+0.24%)
03:41PMTheravance Shares Rise on Approval of Glaxo's COPD Therapy Zacks
Nov-16-17$37.5 (-0.79%)
06:25AMTheravance Biopharma Undervalued Catalysts Seekingalpha
Nov-14-17$37.85 (+0.75%)
03:53PMTheravance (TBPH) Submits NDA for COPD Candidate Revefenacin Zacks
12:14PMDaily Pharma Scoop Heron Undervalued Theravance Submits Nda Nektar Continues Surge Seekingalpha
08:00AM3 Things Biotech Learn Today November 14 2017 Seekingalpha
05:33AMSun Pharma Faces Generic Slump Hamstrung by Plant Restrictions Bloomberg
Nov-13-17$37.57 (-1.55%)
11:48AMTeva: It’s Never Too Late to Sell Barron's
Nov-10-17$38.16 (+0.21%)
03:30PMMomenta Pharmaceuticals, Inc.'s Rough Month Fool
01:45PMSum Fears Small Pharma Seekingalpha
Nov-09-17$38.08 (+2.26%)
02:52PMPerrigo: Crushed It! Barron's
08:00AM3 Things Biotech Learn Today November 9 2017 Seekingalpha
Nov-08-17$37.24 (+1.55%)
11:04AMMallinckrodt: Look Out Below! Barron's
07:16AMKey Predictions for Q3 Earnings Reports of PBYI, XON, LGND Zacks
Nov-07-17$36.67 (-1.93%)
01:41PMWhy Teva Pharma Could Fall Another 50% Barron's
12:45PMTeva Pharma: Junk Rating Adds to Woes Barron's
12:01PMDaily Pharma Scoop Anxious Time Dynavax Longs Vbl Therapeutics Gets Boost Roche Gets 2 Fda Seekingalpha
07:15AMWall Street Breakfast Stock Rally Keeps Going Seekingalpha
Nov-06-17$37.39 (+4.68%)
04:06PMCrude Oil, Energy Rally Give Wall Street Fuel to Close at Records theStreet
03:31PMMylan Inc 2017 Q3 Results Earnings Call Slides Seekingalpha
03:16PMForget Mylan N.V.'s Dismal Third-Quarter Results -- Its Future Is Looking Better Fool
02:27PMWill Mylan Crush Teva’s Generic Dreams? Barron's
11:23AMWall Street Diverges as Energy Rallies and Telecoms Sink theStreet
11:04AMMylan (MYL) Misses on Earnings and Sales Estimates in Q3 Zacks
10:55AMValeant: Fixing a Billion Dollar Mistake? Barron's
10:19AMMylan: Bad Earnings, Good News? Barron's
09:38AMStocks Hold Close to Flat as Broadcom, Qualcomm Lead Nasdaq Higher theStreet
09:37AMAll Eye On Qualcomm-Broadcom Landmark Deal Zacks
09:26AMQualcomm Looks to Reject Broadcom Offer, and Much More Zacks
08:54AMMylan shares trade higher after full-year forecast raised, shrugging off lower third-quarter sales cnbc
07:52AMNasdaq, Dow Futures Rise After Broadcom Makes Bid for Qualcomm theStreet
07:28AMMylan (MYL) Misses on Q3 Earnings & Sales Zacks
07:17AMMylan shares tumble 4% premarket after third-quarter earnings fall short MarketWatch
06:27AMFutures point to a mixed open on Wall Street, as CVS, Mylan, Etsy earnings take center stage cnbc
06:06AMOil Prices, Sprint, Qualcomm and Wilbur Ross - 5 Things You Must Know Before the Market Opens Monday theStreet
04:35AMAllergans Q3 Proves Growth Dead Seekingalpha
07:04PMFutures Up After Lukewarm Jobs Report Friday theStreet
12:10PMEarningsWatch: Disney, Nvidia, Snap headline a week of media and tech MarketWatch
09:44AMSurprise Arrest of Saudi Billionaire Alwaleed Bin Talal Overshadows Big Earnings theStreet
Nov-03-17$35.72 (+1.08%)
02:01PMBiotech Forum Daily Digest Behind Neurocrines Big 3rd Quarter Beat Seekingalpha
12:30PMTeva Punished Weak Outlook Seekingalpha
11:02AMTeva (TEVA) Stock Plunges 20% on Q3 Earnings Miss & View Cut Zacks
10:05AMWill Tinder & PMC Growth Aid Match Group (MTCH) Q3 Earnings? Zacks
09:21AMWill Regeneron Pharma (REGN) Disappoint in Q3 Earnings? Zacks
08:19AMKey Predictions for Q3 Earnings Reports of MYL, HZNP & KERX Zacks
07:32AMIs a Surprise Coming for Mylan (MYL) This Earnings Season? Zacks
06:59AMWall Street Breakfast Jobs Report Show Storm Recovery Seekingalpha
Nov-02-17$35.34 (-4.1%)
08:46PMThe Single Biggest Reason Teva Pharmaceutical Industries Imploded and Fell 22% in October Fool
05:09PMTevas Q3 Crash Bear Reviews Updates Story Seekingalpha
02:06PMWhy Teva Pharmaceutical Is Crashing Today Fool
01:59PMMomenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows Zacks
01:28PMTevas Troubles Just Beginning Seekingalpha
11:18AMHorizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised) Zacks
10:56AMTeva’s latest quarter was even worse than already-low expectations MarketWatch
10:41AMTeva Stock Plunges on Earnings Results, but It's Still Not a Buy theStreet
09:15AMSucampo (SCMP) Beats on Q3 Earnings & Revenues, Ups '17 View Zacks
07:15AMHorizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? Zacks
Nov-01-17$36.85 (+3.19%)
05:57PMMylan Halloween Selloff Expanded State Probe Provides Great Buying Opportunity Seekingalpha
04:30PMWhy Momenta Pharmaceuticals Fell 12.6% Today Fool
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
08:29AMMomenta shares plunge 14% on Q3 profit, revenue misses MarketWatch
05:43AMQuanta Services (PWR) Poised to Beat Q3 Earnings: Here's Why Zacks
05:35AMHigh Collection Revenues to Aid Republic (RSG) Q3 Earnings? Zacks
05:29AMWill Higher Research Revenues Aid Gartner (IT) Q3 Earnings? Zacks
Oct-31-17$35.71 (-6.62%)
04:47PMWhy Qualcomm, Shopify, and Mylan Slumped Today Fool
02:14PMMylan: Can 18 Companies Collude? Barron's
01:52PMStates Target Mylan President, Emcure Exec in Generic Drug Lawsuit theStreet
01:19PMTeva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt MarketWatch
12:20PMUS states to expand generic drug price-fixing suit: Report cnbc
12:18PMMylan shares drop 6% on report of investigation into company president MarketWatch
10:56AMMylan Exec Targeted by States in Generic Drug Pricing Probe Bloomberg
09:13AMCan Parker-Hannifin (PH) Maintain its Earnings Streak in Q1? Zacks
08:51AMIs a Beat in the Cards for Mylan (MYL) This Earnings Season? Zacks
Oct-30-17$38.24 (-0.29%)
10:31AMIs a Turnaround in Store for Teva (TEVA) in Q3 Earnings? Zacks
09:27AMWill Weak End Markets Hurt Flowserve's (FLS) Q3 Earnings? Zacks
09:07AMGoPro (GPRO) to Report Q3 Earnings: Another Beat in Store? Zacks
08:07AMPerrigo Base Plus Plus Strategy Plus Seekingalpha
07:10AMPuerto Rico's 90,000-person healthcare industry is under pressure after storms theStreet
Oct-27-17$38.35 (-0.57%)
11:44AMHere’s why Aetna-CVS may be the last blockbuster deal you see for a while MarketWatch
07:50AMPharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers Zacks
12:53AMMylan Teva Generic Delzicol Sting Allergan Seekingalpha
Oct-26-17$38.57 (-1.15%)
11:31AMGlaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down Zacks
07:37AM3 Value Stocks for Smart Investors Fool
07:35AMMylan shares rise 1.7% premarket on UK patent win MarketWatch
Oct-25-17$39.02 (+0.26%)
09:55AMAdamis Pharmaceuticals Rocket Counting Lift Seekingalpha
08:47AMGreenlight Q3 Letter Bubble Basket Seekingalpha
04:47AMSanofi sues Mylan in U.S., alleging patent breach MarketWatch
Oct-23-17$38.47 (-0.1%)
05:43AMAllergan Linzess Restasis 2_0 Seekingalpha
08:02AMCan Teva Pharmaceutical's Dividend Even Survive? Fool
Oct-20-17$38.51 (+0.57%)
02:19PMAllergan: A Splitting Headache? Barron's
Oct-19-17$38.29 (+2.08%)
11:03AMAllergan: All In or Fall Out? Barron's
Oct-18-17$37.51 (-2.67%)
05:55PMThe Biggest Loser: Allergan’s Patent Troubles Barron's
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
12:28PMShares of large generic drugmakers fall MarketWatch
10:10AMIs a Breakup Allergan’s Best Bet? Barron's
Oct-17-17$38.54 (+0.94%)
04:44PMAllergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall Zacks
03:59PMAnd For Allergen’s Next Trick..Filling a $1.5 Billion Hole? Barron's
03:45PMAdamis Pharmaceuticals Buy Dip Ahead Symjepi Partnership Launch Seekingalpha
09:06AMAllergan Punished Judge Invalidates Restasis Patents Seekingalpha
Oct-16-17$38.18 (+0.61%)
03:35PMAllergan Loses a Patent Battle…Has It Lost the War? Barron's
02:23PMJudge invalidates Allergan patents on dry-eye medicine Restasis cnbc
Oct-13-17$37.95 (+0.5%)
01:38PMTeva Rushes Match 30 Percent Discounts Generic Copaxone Seekingalpha
07:42AMVoyager Therapeutics (VYGR) Jumps: Stock Rises 7.8% Zacks
01:15AMA New FDA Approval Sends Small Cap Flexion Soaring Fool
Oct-11-17$38.29 (-0.42%)
10:50AMAllergan Bulls Brace Generic Restasis Seekingalpha
08:30AMMylan Gets Complete Response Letter For Biosimilar Neulasta Zacks
07:20AMMylan Deals a Blow to Teva Pharmaceutical Fool
Oct-10-17$38.45 (+0.52%)
07:30PMHealth insurers, hospitals and generic-drug makers ask Congress to examine Allergan patent deal cnbc
07:00PMAmgen Wins Reprieve on Its 2nd-Best-Selling Drug Fool
Oct-09-17$38.25 (-0.1%)
09:32AMValeant’s Biggest Drug Gets a Shot at More Sales Barron's
12:50AMAntares Pharma Will October Deliver Triple Play Seekingalpha
10:34AM3 Drug Stocks That Soared This Week: Are They Buys? Fool
Oct-06-17$38.29 (+0.98%)
11:00AMIs Allergan plc a Bargain After a $7.6 Billion Dip in September? Fool
Oct-05-17$37.92 (+0.32%)
08:55PMValuation Dashboard Healthcare Update Seekingalpha
05:52PMInterview Shire Controversial Dry Eye Market Seekingalpha
12:30PMTime Trust Gilead Seekingalpha
11:02AMTeva Fdas Bombshell Seekingalpha
06:49AMMylan Generic Copaxone Punish Teva Seekingalpha
04:27AMTeva Might Getting Sicker Stock Drops Seekingalpha
Oct-04-17$37.8 (+16.2%)
04:25PMTeva Copaxone Competition Comes Worst Time Seekingalpha
03:52PMThe Hot Stock: My Oh Mylan! Barron's
03:40PMMylan Way 60 Seekingalpha
09:37AMMylan’s surprise generic win sends Teva, Momenta shares plunging MarketWatch
08:55AMTeva: Yes, There’s a Bright Side Barron's
07:48AMMorning Movers: Mylan Soars, Teva Tumbles, PepsiCo Drops Barron's
05:32AMMylan jumps 15% premarket after FDA OK for MS drug MarketWatch
05:32AMMylan jumps 15% premarket after FDA OK for MS drug MarketWatch
Oct-02-17$32.39 (+4.96%)
11:11AMRoche Shoring Biosimilar Wave Seekingalpha
10:22AMAntares Numerous Upcoming Catalysts Seekingalpha
04:50AMMohawk Tribe Attempts Dismiss Allergan Patent Case Seekingalpha
Sep-19-17$30.98 (-1.65%)
10:03AMMylan Time Sell Seekingalpha
Sep-18-17$31.5 (-1.65%)
10:06AMMylan Attacks Allergans Desperate Measures Protect Restasis Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat